Working Definitions I GENERAL
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Risk Factors Associated with the Development
Biomédica 2017;37(Supl.1):2017;37(Supl.1):51-651-6 Risk factors of perinatal asphyxia doi: http://dx.doi.org/10.7705/biomedica.v37i1.2844 ORIGINAL ARTICLE Risk factors associated with the development of perinatal asphyxia in neonates at the Hospital Universitario del Valle, Cali, Colombia, 2010-2011 Javier Torres-Muñoz, Christian Rojas, Diana Mendoza-Urbano, Darly Marín-Cuero, Sandra Orobio, Carlos Echandía Grupo INSIDE, Departamento de Pediatría, Facultad de Medicina, Universidad del Valle, Cali, Colombia Introduction: Perinatal asphyxia is one of the main causes of perinatal mortality and morbidity worldwide and it generates high costs for health systems; however, it has modifiable risk factors. Objective: To identify the risk factors associated with the development of perinatal asphyxia in newborns at Hospital Universitario del Valle, Cali, Colombia. Materials and methods: Incident cases and concurrent controls were examined. Cases were defined as newborns with moderate to severe perinatal asphyxia who were older than or equal to 36 weeks of gestational age, needed advanced resuscitation and presented one of the following: early neurological disorders, multi-organ commitment or a sentinel event. The controls were newborns without asphyxia who were born one week apart from the case at the most and had a comparable gestational age. Patients with major congenital malformations and syndromes were excluded. Results: Fifty-six cases and 168 controls were examined. Premature placental abruption (OR=41.09; 95%CI: 4.61-366.56), labor with a prolonged expulsive phase (OR=31.76; 95%CI: 8.33-121.19), lack of oxytocin use (OR=2.57; 95% CI: 1.08 - 6.13) and mothers without a partner (OR=2.56; 95% CI: 1.21-5.41) were risk factors for the development of perinatal asphyxia in the study population. -
Routine Administration of Vitamin K1 Prophylaxis to the Newborn
Routine Administration of Vitamin K1 Prophylaxis to the Newborn Practice Resource for Health Care Providers July 2016 Practice Resource Guide: ROUTINE ADMINISTRATION OF VITAMIN K1 PROPHYLAXIS TO THE NEWBORN The information attached is the summary of the position statement and the recommendations from the recent CPS evidence-based guideline for routine intramuscular administration of Vitamin K1 prophylaxis to the newborn*: www.cps.ca/documents/position/administration-vitamin-K-newborns Summary Vitamin K deficiency bleeding or VKDB (formerly known as hemorrhagic disease of the newborn or HDNB) is significant bleeding which results from the newborn’s inability to sufficiently activate vitamin K-dependent coagulation factors because of a relative endogenous and exogenous deficiency of vitamin K.1 There are three types of VKDB: 1. Early onset VKDB, which appears within the first 24 hours of life, is associated with maternal medications that interfere with vitamin K metabolism. These include some anticonvulsants, cephalosporins, tuberculostatics and anticoagulants. 2. Classic VKDB appears within the first week of life, but is rarely seen after the administration of vitamin K. 3. Late VKDB appears within three to eight weeks of age and is associated with inadequate intake of vitamin K (exclusive breastfeeding without vitamin K prophylaxis) or malabsorption. The incidence of late VKDB has increased in countries that implemented oral vitamin K rather than intramuscular administration. There are three methods of Vitamin K1 administration: intramuscular, oral and intravenous. The Canadian Paediatric Society (2016)2 and the American Academy of Pediatrics (2009)3 recommend the intramuscular route of vitamin K administration. The intramuscular route of Vitamin K1 has been the preferred method in North America due to its efficacy and high compliance rate. -
Quality of Survival After Severe Birth Asphyxia
Arch Dis Child: first published as 10.1136/adc.52.8.620 on 1 August 1977. Downloaded from Archives of Disease in Childhood, 1977, 52, 620-626 Quality of survival after severe birth asphyxia ALISON J. THOMSON, MARGARET SEARLE, AND G. RUSSELL From Aberdeen Maternity Hospital and the Royal Aberdeen Children's Hospital SUMMARY Thirty-one children who survived severe birth asphyxia defined by a 1-minute Apgar score of 0, or a 5-minute Apgar score of <4, have been seen at age 5 to 10 years for neurological and psychological assessment. Their progress has been compared with that of controls matched for sex, birthweight, gestational age, and social class. 29 (93 %) of the 31 asphyxiated group and all the controls had no serious neurological or mental handicap. 2 were severely disabled and mentally retarded. Detailed studies of psychological function showed no significant differences between the two groups. 2 apparently stillborn infants have made normal progress. It was not possible to identify any perinatal factor which predicted the occurrence of serious handicap with certainty. We considered that the quality of life enjoyed by the large majority of the survivors was such as to justify a positive approach to the resuscitation of very severely asphyxiated neonates. Perinatal asphyxia is a major cause of morbidity and Patients and methods mortality in the first week of life. The survivors have long been recognized to have an increased risk of Cases. In 1964-68 inclusive there were 14 890 single- handicaps such as cerebral palsy, mental retarda- ton live births to mothers living in the city and copyright. -
Meconium Aspiration Syndrome
National Neonatal Perinatal Database 2002-2003 Meconium Aspiration Syndrome Subjects and Methods 145,623 neonates born at 18 centers of National Neonatal-Perinatal Database (NNPD) of India over two year duration (2002-2003) Management of Meconium-stained amniotic fluid Contemporary recommendations of American Academy of Pediatrics and American Heart Association through Neonatal Resuscitation Program and Pediatric Working Group of International Liaison Committee on Resuscitation were expected to be followed. Management of a neonate born through MSAF comprised: 1) Suctioning the mouth, pharynx and nose as soon as head was delivered before delivery of shoulders (intrapartum suctioning) regardless of whether the meconium is thick or thin, and 2) if the infant was non-vigorous, intubating and suctioning the trachea before performing other steps of resuscitation. Meconium aspiration syndrome MAS was defined as presence of two of the following: meconium staining of liquor or staining of nails or umbilical cord or skin, respiratory distress within one hour of birth and radiological evidence of aspiration pneumonitis (atelectasis and/or hyperinflation). Findings Figure 1: Management and outcome of neonates born through meconium stained amniotic fluid Meconium-stained amniotic fluid (MSAF) (n=12,156) 8.4% of live births Among neonates with MSAF (n=12,156) Endotracheal suction in 3468 (28.5%) Need of positive pressure ventilation in During 2504 (20.6%) Resuscitation Resuscitation Need of chest compression in 1021 (8.4%) Among neonates with MSAF (n=12,156) MAS in 1896 (15.6%) Morbidities Morbidities HIE in 846 (7%) Among neonates with MAS (n=1,896) Assisted ventilation in 385 (20.3%) Outcome Death in 332 (17.5%) Mean birth weight of babies born through MSAF was significantly lower (2646552 gm vs. -
Vitamin K for the Prevention of Vitamin K Deficiency Bleeding (VKDB)
Title: Vitamin K for the Prevention of Vitamin K Deficiency Bleeding (VKDB) in Newborns Approval Date: Pages: NEONATAL CLINICAL February 2018 1 of 3 Approved by: Supercedes: PRACTICE GUIDELINE Neonatal Patient Care Teams, HSC & SBH SBH #98 Women’s Health Maternal/Newborn Committee Child Health Standards Committee 1.0 PURPOSE 1.1 To ensure all newborns are properly screened for the appropriate Vitamin K dose and route of administration and managed accordingly. Note: All recommendations are approximate guidelines only and practitioners must take in to account individual patient characteristics and situation. Concerns regarding appropriate treatment must be discussed with the attending neonatologist. 2.0 PRACTICE OUTCOME 2.1 To reduce the risk of Vitamin K deficiency bleeding. 3.0 DEFINITIONS 3.1 Vitamin K deficiency bleeding (VKDB) of the newborn: previously referred to as hemorrhagic disease of the newborn. It is unexpected and potentially severe bleeding occurring within the first week of life. Late onset VKDB can also occur in infants 2-12 weeks of age with severe vitamin k deficiency. Bleeding in both types is primarily gastro-intestinal and intracranial. 3.2 Vitamin K1: also known as phytonadione, an important cofactor in the synthesis of blood coagulation factors II, VII, IX and X. 4.0 GUIDELINES Infants greater than 1500 gm birthweight 4.1 Administer Vitamin K 1 mg IM as a single dose within 6 hours of birth. 4.1.1 The infant’s primary health care provider (PHCP): offer all parents the administration of vitamin K intramuscularly (IM) for their infant. 4.1.2 If parent(s) refuse any vitamin K administration to the infant, discuss the risks of no vitamin K administration, regardless of route, with the parent(s). -
Asphyxia Neonatorum
CLINICAL REVIEW Asphyxia Neonatorum Raul C. Banagale, MD, and Steven M. Donn, MD Ann Arbor, Michigan Various biochemical and structural changes affecting the newborn’s well being develop as a result of perinatal asphyxia. Central nervous system ab normalities are frequent complications with high mortality and morbidity. Cardiac compromise may lead to dysrhythmias and cardiogenic shock. Coagulopathy in the form of disseminated intravascular coagulation or mas sive pulmonary hemorrhage are potentially lethal complications. Necrotizing enterocolitis, acute renal failure, and endocrine problems affecting fluid elec trolyte balance are likely to occur. Even the adrenal glands and pancreas are vulnerable to perinatal oxygen deprivation. The best form of management appears to be anticipation, early identification, and prevention of potential obstetrical-neonatal problems. Every effort should be made to carry out ef fective resuscitation measures on the depressed infant at the time of delivery. erinatal asphyxia produces a wide diversity of in molecules brought into the alveoli inadequately com Pjury in the newborn. Severe birth asphyxia, evi pensate for the uptake by the blood, causing decreases denced by Apgar scores of three or less at one minute, in alveolar oxygen pressure (P02), arterial P02 (Pa02) develops not only in the preterm but also in the term and arterial oxygen saturation. Correspondingly, arte and post-term infant. The knowledge encompassing rial carbon dioxide pressure (PaC02) rises because the the causes, detection, diagnosis, and management of insufficient ventilation cannot expel the volume of the clinical entities resulting from perinatal oxygen carbon dioxide that is added to the alveoli by the pul deprivation has been further enriched by investigators monary capillary blood. -
Postnatal Complications of Intrauterine Growth Restriction
Neonat f al l o B Sharma et al., J Neonatal Biol 2016, 5:4 a io n l r o u g y DOI: 10.4172/2167-0897.1000232 o J Journal of Neonatal Biology ISSN: 2167-0897 Mini Review Open Access Postnatal Complications of Intrauterine Growth Restriction Deepak Sharma1*, Pradeep Sharma2 and Sweta Shastri3 1Neoclinic, Opposite Krishna Heart Hospital, Nirman Nagar, Jaipur, Rajasthan, India 2Department of Medicine, Mahatma Gandhi Medical College, Jaipur, Rajasthan, India 3Department of Pathology, N.K.P Salve Medical College, Nagpur, Maharashtra, India Abstract Intrauterine growth restriction (IUGR) is defined as a velocity of fetal growth less than the normal fetus growth potential because of maternal, placental, fetal or genetic cause. This is an important cause of fetal and neonatal morbidity and mortality. Small for gestational age (SGA) is defined when birth weight is less than two standard deviations below the mean or less than 10th percentile for a specific population and gestational age. Usually IUGR and SGA are used interchangeably, but there exists subtle difference between the two terms. IUGR infants have both acute and long term complications and need regular follow up. This review will cover various postnatal aspects of IUGR. Keywords: Intrauterine growth restriction; Small for gestational age; Postnatal Diagnosis of IUGR Placental genes; Maternal genes; Fetal genes; Developmental origin of health and disease; Barker hypothesis The diagnosis of IUGR infant postnatally can be done by clinical examination (Figure 2), anthropometry [13-15], Ponderal Index Introduction (PI=[weight (in gram) × 100] ÷ [length (in cm) 3]) [2,16], Clinical assessment of nutrition (CAN) score [17], Cephalization index [18], Intrauterine growth restriction (IUGR) is defined as a velocity of mid-arm circumference and mid-arm/head circumference ratios fetal growth less than the normal fetus growth potential for a specific (Kanawati and McLaren’s Index) [19]. -
Respiratory and Gastrointestinal Involvement in Birth Asphyxia
Academic Journal of Pediatrics & Neonatology ISSN 2474-7521 Research Article Acad J Ped Neonatol Volume 6 Issue 4 - May 2018 Copyright © All rights are reserved by Dr Rohit Vohra DOI: 10.19080/AJPN.2018.06.555751 Respiratory and Gastrointestinal Involvement in Birth Asphyxia Rohit Vohra1*, Vivek Singh2, Minakshi Bansal3 and Divyank Pathak4 1Senior resident, Sir Ganga Ram Hospital, India 2Junior Resident, Pravara Institute of Medical Sciences, India 3Fellow pediatrichematology, Sir Ganga Ram Hospital, India 4Resident, Pravara Institute of Medical Sciences, India Submission: December 01, 2017; Published: May 14, 2018 *Corresponding author: Dr Rohit Vohra, Senior resident, Sir Ganga Ram Hospital, 22/2A Tilaknagar, New Delhi-110018, India, Tel: 9717995787; Email: Abstract Background: The healthy fetus or newborn is equipped with a range of adaptive, strategies to reduce overall oxygen consumption and protect vital organs such as the heart and brain during asphyxia. Acute injury occurs when the severity of asphyxia exceeds the capacity of the system to maintain cellular metabolism within vulnerable regions. Impairment in oxygen delivery damage all organ system including pulmonary and gastrointestinal tract. The pulmonary effects of asphyxia include increased pulmonary vascular resistance, pulmonary hemorrhage, pulmonary edema secondary to cardiac failure, and possibly failure of surfactant production with secondary hyaline membrane disease (acute respiratory distress syndrome).Gastrointestinal damage might include injury to the bowel wall, which can be mucosal or full thickness and even involve perforation Material and methods: This is a prospective observational hospital based study carried out on 152 asphyxiated neonates admitted in NICU of Rural Medical College of Pravara Institute of Medical Sciences, Loni, Ahmednagar, Maharashtra from September 2013 to August 2015. -
Perinatal Asphyxia Neonatal Therapeutic Hypothermia
PERINATAL ASPHYXIA NEONATAL THERAPEUTIC HYPOTHERMIA Sergio G. Golombek, MD, MPH, FAAP Professor of Pediatrics & Clinical Public Health – NYMC Attending Neonatologist Maria Fareri Children’s Hospital - WMC Valhalla, New York President - SIBEN ASPHYXIA From Greek [ἀσφυξία]: “A stopping of the pulse” “Loss of consciousness as a result of too little oxygen and too much CO2 in the blood: suffocation causes asphyxia” (Webster’s New World Dictionary) On the influence of abnormal parturition, difficult labours, premature birth, and asphyxia neonatorum, on the mental and physical condition of the child, especially in relation to deformities. By W. J. Little, MD (Transactions of the Obstetrical Society of London 1861;3:243-344) General spastic contraction of the lower Contracture of adductors and flexors of lower extremities. Premature birth. Asphyxia extremities. Left hand weak. Both hands awkward. neonatorum of 36 hr duration. Hands More paralytic than spastic. Born with navel-string unaffected. (Case XLVII) around neck. Asphyxia neonatorum 1 hour. (Case XLIII) Perinatal hypoxic-ischemic encephalopathy (HIE) Associated with high neonatal mortality and severe long-term neurologic morbidity Hypothermia is rapidly becoming standard therapy for full-term neonates with moderate-to-severe HIE Occurs at a rate of about 3/1000 live-born infants in developed countries, but the rate is estimated to be higher in the developing world Intrapartum-related neonatal deaths (previously called ‘‘birth asphyxia’’) are the fifth most common cause of deaths among children under 5 years of age, accounting for an estimated 814,000 deaths each year, and also associated with significant morbidity, resulting in a burden of 42 million disability adjusted life years (DALYs). -
Vitamin K Information for Parents-To-Be
Vitamin K Information for parents-to-be Maternity This leaflet has been written to help you decide whether your baby should receive a vitamin K supplement at birth. What is vitamin K? Vitamin K is needed for the normal clotting of blood and is naturally made in the bowel. page 2 Why is vitamin K given to newborn babies? All babies are born with low levels of vitamin K. Several days after birth, a baby will normally produce their own supply of vitamin K from natural bacteria found in their bowel. They can also get a small amount of vitamin K from their mother’s breast milk and it is added to formula milk. This can help the natural bacteria in the baby’s bowel to develop, which in turn improves their levels of vitamin K. However, babies are more at risk of developing vitamin K deficiency until they are feeding well. A deficiency in vitamin K is the main cause of vitamin K deficiency bleeding (VKDB). This can cause bleeding from the belly button, nose, surgical sites (i.e. following circumcision), and (rarely) in the brain. The risk of this happening is approximately 1 in 100,000 for full term babies. VKDB is a serious disorder, which may lead to internal bleeding. Signs of internal bleeding are: • blood in the nappy • oozing (bleeding) from the cord • nose bleeds • bleeding from scratches which doesn’t stop on its own • bruising • prolonged jaundice (yellowing of the skin) at three weeks if breast feeding and two weeks if formula feeding. VKDB can also lead to bleeding on the brain, which can cause brain damage and/or death. -
Perinatal Asphyxia in the Term Newborn
www.jpnim.com Open Access eISSN: 2281-0692 Journal of Pediatric and Neonatal Individualized Medicine 2014;3(2):e030269 doi: 10.7363/030269 Received: 2014 Oct 01; accepted: 2014 Oct 14; published online: 2014 Oct 21 Review Perinatal asphyxia in the term newborn Roberto Antonucci1, Annalisa Porcella1, Maria Dolores Pilloni2 1Division of Neonatology and Pediatrics, “Nostra Signora di Bonaria” Hospital, San Gavino Monreale, Italy 2Family Planning Clinic, San Gavino Monreale, ASL 6 Sanluri (VS), Italy Proceedings Proceedings of the International Course on Perinatal Pathology (part of the 10th International Workshop on Neonatology · October 22nd-25th, 2014) Cagliari (Italy) · October 25th, 2014 The role of the clinical pathological dialogue in problem solving Guest Editors: Gavino Faa, Vassilios Fanos, Peter Van Eyken Abstract Despite the important advances in perinatal care in the past decades, asphyxia remains a severe condition leading to significant mortality and morbidity. Perinatal asphyxia has an incidence of 1 to 6 per 1,000 live full-term births, and represents the third most common cause of neonatal death (23%) after preterm birth (28%) and severe infections (26%). Many preconceptional, antepartum and intrapartum risk factors have been shown to be associated with perinatal asphyxia. The standard for defining an intrapartum hypoxic-ischemic event as sufficient to produce moderate to severe neonatal encephalopathy which subsequently leads to cerebral palsy has been established in 3 Consensus statements. The cornerstone of all three statements is the presence of severe metabolic acidosis (pH < 7 and base deficit ≥ 12 mmol/L) at birth in a newborn exhibiting early signs of moderate or severe encephalopathy. Perinatal asphyxia may affect virtually any organ, but hypoxic-ischemic encephalopathy (HIE) is the most studied clinical condition and that is burdened with the most severe sequelae. -
Neurological Sequelae in Newborn Babies After Perinatal Asphyxia
Arch Dis Child: first published as 10.1136/adc.53.7.564 on 1 July 1978. Downloaded from Archives of Disease in Childhood, 1978, 53, 564-569 Neurological sequelae in newborn babies after perinatal asphyxia S. W. DE SOUZA AND B. RICHARDS From the University Department of Child Health, St Mary's Hospital, Manchester, and the Department of Computation, University of Manchester Institute of Science and Technology, Manchester SUMMARY A total of 53 babies, 37 to 44 weeks' gestational age with a history of fetal distress in labour, and severe neurological abnormalities in the early newborn period, were followed up for between 2 and 5 years. Their progress was compared with an equal number of normal babies matched for gestational age, birthweight, sex, and social class, but without a history of fetal distress or delay in establishing spontaneous respiration at birth. In the set of babies with a history of fetal distress no perinatal condition was identified that could predict with certainty the type of neurological status in the newborn period, or the occurrence of neurological abnormality in later childhood. Follow-up disclosed a considerable improvement in function in most of the apparently brain-injured babies. It is suggested that such babies exhibiting apathy initially but subsequently hyperexcitability and extensor hypertonia carry the worst prognosis. It has long been known that perinatal asphyxia babies were also seen by one of us (S.W. De S.). sometimes causes brain damage but there is un- They were born between 1971 and 1975 at St Mary's certainty about the sequence ofevents and prognostic Hospital, Manchester.